Dimensional Fund Advisors’s Immune Design Corp. IMDZ Stock Holding History

Dimensional Fund Advisors’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-629,658	Closed	-$3.68M	–	3523
2019 Q1	$3.68M	Sell	629,658 -15,350	-2%	-$52.3K	﹤0.01%	2737
2018 Q4	$839K	Sell	645,008 -16,953	-3%	-$29.5K	﹤0.01%	3052
2018 Q3	$2.28M	Buy	661,961 +214,935	+48%	+$807K	﹤0.01%	2894
2018 Q2	$2.03M	Buy	447,026 +254,696	+132%	+$1.01M	﹤0.01%	2885
2018 Q1	$635K	Buy	192,330 +157,784	+457%	+$559K	﹤0.01%	3072
2017 Q4	$135K	Buy	34,546 +15,650	+83%	+$85.2K	﹤0.01%	3259
2017 Q3	$196K	Hold	18,896	–	–	﹤0.01%	3228
2017 Q2	$184K	Buy	18,896 +1,600	+9%	+$11.2K	﹤0.01%	3207
2017 Q1	$118K	Buy	+17,296	New	+$100K	﹤0.01%	3237

Dimensional Fund Advisors's IMDZ Position: Q2 2019 in Review

Dimensional Fund Advisors sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 629,658 shares — an estimated $3.68M sold.

Dimensional Fund Advisors first reported a position in IMDZ in Q1 2017 and held it in 9 quarters. The position peaked at $3.68M in Q1 2019. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.

Dimensional Fund Advisors reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
Dimensional Fund Advisors sold 629,658 Immune Design Corp. shares in Q2 2019, an estimated $3.68M.
Dimensional Fund Advisors first reported a position in Immune Design Corp. in Q1 2017 and held it in 9 quarters.
Dimensional Fund Advisors's Immune Design Corp. position peaked at $3.68M in Q1 2019.
0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.

Based on Dimensional Fund Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.